pAAV-2X(CMV-eBFP2-3XNLS-pA)
(Plasmid
#195867)
-
Purposeto express nuclear localized eBFP2
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 195867 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 |
Backbone
-
Vector backboneUnspecified
-
Vector typeAAV
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameeBFP2
-
SpeciesOther
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Unknown (unknown if destroyed)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byAddgene plasmid 14893
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAV-2X(CMV-eBFP2-3XNLS-pA) was a gift from Jonathan Ploski (Addgene plasmid # 195867 ; http://n2t.net/addgene:195867 ; RRID:Addgene_195867) -
For your References section:
Adeno-Associated Viral Vector Resource for the RNA-Targeting Cas13d: A Comparison of High-Fidelity Variants, DjCas13d and hfCas13d. Back F, Sandoval A, Vu L, Hong VM, Bhaskara A, Rodriguez SR, O’Brien JT, Kolber BJ, Kroener S, Ploski JE. Mol Ther Methods Clin Dev, 20 Aug 2025, 101565 10.1016/j.omtm.2025.101565